Remdesivir Compulsory Licensing Issuance Rejected by Russia

in remdesivirlicensing •  3 years ago 

Russia’s Supreme Court rejected US Company Gilead Sciences lawsuit challenging the Russian government’s decision for development and marketing anti-covid-19 drug Remdesivir with the consent of Gilead. Read more: https://bit.ly/3wdduvk

Russia-Rejects-Gilead’s-Plea-over-Issuance-of-Compulsory-Licensing-on-Remdesivir.jpg

Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!